Re
Replicate Bio
San Diego CAFounded 202120 employees
Private CapbiotechPrivateOncology
Platform: Synthetic Bio
Market Cap
N/A
All Drugs
2
Clinical Trials
6
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Motarasimod | REP-7974 | Phase 2 | 2 | PCSK9 | MGBreast Ca | ||
| Terarelsin | REP-9980 | Phase 3 | 4 | KRASG12C | HSBladder Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)